Hydroxyurea therapy in UK children with sickle cell anaemia: A single‐centre experience

Abstract

This study demonstrates the effectiveness and safety in practice of high-dose hydroxyurea as a disease-modifying therapy, which we advocate for all children with sickle cell anaemia.